Delgocitinib Leads to Strong 16-Week Improvement in Chronic Hand Eczema The American Journal of Managed Care® (AJMC®) Source link
Eczema treatment success sparks call for urgent policy change Region Canberra Source link
This biopharma stock could more than double on oral eczema treatment, Goldman Sachs says CNBC Source link
FDA Accepts sNDA for Delgocitinib Cream to Treat Pediatric Chronic Hand Eczema Dermatology Times Source link